About
Tourette's Treatment
Areas of Focus
Categories
Small Molecule PharmaceuticalMidwest
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
17
As Collaborator
0
Total Enrollment
1,041
By Phase
PHASE1: 8PHASE3: 3PHASE2: 5
By Status
COMPLETED: 13TERMINATED: 2ACTIVE_NOT_RECRUITING: 1TEMPORARILY_NOT_AVAILABLE: 1
Clinical Trials Pipeline16 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06669091Lead Sponsor
Food-effect Study of Ecopipam Pharmacokinetics
PHASE1Completed
25 participants
Started: Nov 5, 2024 · Completed: Dec 27, 2024
NCT06194864Lead Sponsor
Drug Interaction Study
PHASE1Completed
45 participants
Started: Jan 18, 2024 · Completed: May 22, 2024
NCT06021522Lead Sponsor
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
PHASE3Active, not recruiting
150 participants
Started: Aug 16, 2023 · Completed: Mar 31, 2027
NCT05841160Lead Sponsor
Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
PHASE1Completed
29 participants
Started: Mar 15, 2023 · Completed: May 12, 2023
NCT05615220Lead Sponsor
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
PHASE3Completed
216 participants
Started: Jan 31, 2023 · Completed: Feb 4, 2025
Locations (1)
Headquarters
Chicago, IL, United States
Map
Loading map...